Rights and permissions
About this article
Cite this article
Rofecoxib, valdecoxib and celecoxib increase risk of MI in rheumatic disease. Inpharma Wkly. 1615, 12 (2007). https://doi.org/10.2165/00128413-200716150-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200716150-00020